Cutler Group LP Ab Cellera Biologics Inc. Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$9.48 - $14.52 $25,159 - $38,536	2,654 Added 39.34%	9,400 $95,000
Q3 2022 Oct 25, 2022	BUY	$9.2 - $13.68 $62,063 - $92,285	6,746 New	6,746 $66,000
Q1 2022 Apr 14, 2022	SELL	$7.46 - $14.14 $23,804 - $45,120	-3,191 Reduced 59.19%	2,200 $21,000
Q4 2021 Jan 18, 2022	BUY	$12.99 - $17.73 $59,766 - $81,575	4,601 Added 582.41%	5,391 $77,000
Q3 2021 Oct 26, 2021	SELL	$14.85 - $21.34 $41,728 - $59,965	-2,810 Reduced 78.06%	790 $15,000
Q2 2021 Jul 19, 2021	BUY	$20.19 - $34.17 $44,418 - $75,174	2,200 Added 157.14%	3,600 $79,000
Q1 2021 Apr 26, 2021	BUY	$23.29 - $53.2 $32,606 - $74,480	1,400 New	1,400 $47,000

155

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $807M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.